Cephalalgia

Article	Citations
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care	109
Harassment in the headache field: a global web-based cross-sectional survey	87
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world	81
High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients	80
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll	68
International Classification of Headache Disorders-4 – Work in Progress 1	62
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials	59
Evidence-based guidelines for the pharmacological treatment of migraine	59
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria	54
Depression screening in migraine - A double-edged sword	54
Assessing migraine therapeutics	51
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization	49
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”	44
Call for papers	42
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex	40
Diagnosis of idiopathic intracranial hypertension - the importance of excluding secondary causes: A systematic review	39
Systemic lupus erythematosus mimicking retinal migraine: a case report	39
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study	36
Effect of Altmetric score on manuscript citations: A randomized-controlled trial	35
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study	35
CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis	32
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa	31
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury	30
An altered reward system characterizes chronic migraine with medication overuse headache	30
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system	28

Childhood and adolescent headache: A problem not to be ignored in the era of new therapies	28
Painful nervus intermedius neuropathy attributed to Bell's palsy: The need for independent diagnostic criteria	28
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment	28
Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study	27
Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions	27
Case reports: Could sexual dysfunction in women with migraine be a side effect of CGRP inhibition?	27
Physical impairment during and between migraine attacks: A daily diary study of patients with chronic migraine	27
Migraine and risk of atrial fibrillation: A 9-year follow-up based on the Trøndelag Health Study	27
COVID-19 vaccination-triggered cluster headache episodes with frequent attacks	27
Galcanezumab modulates Capsaicin-induced C-fiber reactivity	27
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition	26
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks	26
Comorbidity or combination – more evidence for cluster-migraine?	25
Author response to ‘Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications’	25
The midfacial segment pain: little known disorder in need of scientific evaluation	24
Crossing the Rubicon? The future impact of artificial intelligence on headache medicine	23
Sex differences in photophobic behaviors following cortical spreading depression in rats	23
The non-decussating and decussating trigeminothalamic tracts in humans: A combination of connectome-based tractography and histological validation	23
Looking at Cephalalgia from the inside	23
Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®	23
A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants	22
Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks	22
Real-world efficacy of galcanezumab for the treatment of migraine in Korean patients	22
What is the evolutionary disadvantage of migraine?	21
Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection	21
Guidelines Update: Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition – An experience-based update	21
Muscae volitantes: A 19th-century precursor of visual snow syndrome?	20
The “index vein” as a sign for migraine aura in the emergency setting	20
Abstracts from the International Headache Congress 14–17 September 2023	19
Burden of headache in a HIV-positive population of sub-Saharan Africa	19
Thanks to Reviewers	19
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review	18
Abnormal heart rate variability and its application in predicting treatment efficacy in patients with chronic migraine: An exploratory study	18
Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies	18
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process	18
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society	18
Are we closer to achieving precision medicine for migraine treatment? A narrative review	17
Advancing understanding of migraine pathophysiology and therapy by consideration of patient sex	17
Erratum	17
Poor social support and loneliness in chronic headache: Prevalence and effect modifiers	17
The impact of eating disorders on idiopathic intracranial hypertension	17
Psychophysical testing in chronic migraine and chronic tension type headache: An observational study	17
Letter to the Editor regarding “Effect of Altmetric score on manuscript citations: A randomized-controlled trial”	16
Shared genetics and causal relationships between migraine and thyroid function traits	16
Exploring the association between familial hemiplegic migraine genes (CACNA1A, ATP1A2 and SCN1A) with migraine and epilepsy: A UK Biobank exome-wide association study	16
Stroke due to small-vessel disease and migraine: A case–control study of a young adult with ischemic stroke population	16
Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society	16
Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies against CGRP and the CGRP receptor: A retrospective cohort study	16
Corneal confocal microscopy identifies corneal nerve fiber loss in patients with migraine	16
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache	15

Corrigendum: No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study	15
Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension	15
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients	15
Effectiveness of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in menstrually-related migraine: The unmet need of perimenstrual headache days	15
Internet and social media's role in migraine education: Headache or not headache?	15
Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives	15
Premonitory symptoms in migraine: A REFORM Study	15
BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm	15
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent he	15
Board Walk – April 2022	14
Hypnic Headache – What do we know in 2022?	14
Comparison of continuous headache features in youth with migraine, new daily persistent headache, and persistent post-traumatic headache	14
New migraine drugs: A critical appraisal of the reason why the majority of migraine patients do not receive an adequate medication	14
Cigarette smoking history (personal and secondary childhood exposure) in non-cluster headache trigeminal autonomic cephalalgias: A clinic based study	14
Proposed general diagnostic criteria for secondary headaches	14
The long-term effect of work schedule, shift work disorder, insomnia and restless legs syndrome on headache among nurses: A prospective longitudinal cohort study	14
Bridging the gaps of headache care for underserved populations: Current status of the headache field in Latin America	14
Comment on “Lack of reproducibility of resting-state functional MRI findings in migraine with aura”	14
Postprandial fasting related headache during Ramadan in Saudi Arabia: A cross-sectional study	14
“Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials	13
Recurrent Painful Ophthalmoplegic Neuropathy: A case report with atypical features and a review of the literature	13
Prevalence and treatment of typical and atypical headaches in patients with Chiari I malformation: A meta-analysis and literature review	13
Reply to “Methodological considerations in assessing the impact of CGRP monoclonal antibodies on blood pressure”	13
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study	13
Avoidance behaviour modulates but does not condition phonophobia in migraine	13
Longitudinal trajectories of posttraumatic headache after pediatric mild traumatic brain injury	13
Prevalence of neck pain in migraine: A systematic review and meta-analysis	13
Electrophysiological findings in migraine may reflect abnormal synaptic plasticity mechanisms: A narrative review	13
Headache at the chronic stage of cerebral venous thrombosis	13
Children under 6 years with acute headache in Pediatric Emergency Departments. A 2-year retrospective exploratory multicenter Italian study	13
Orofacial pain for clinicians: A review of constant and attack-like facial pain syndromes	12
Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial	12
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab	12
What do people want to know about “Growing Up with Migraine”? Results of a preference survey of people with lived experience to guide future research	12
Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models	12
Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19	12
Oxygen inhalation has no effect on provoked cranial autonomic symptoms using kinetic oscillation stimulation in healthy volunteers	12
Late Breaking Author Index	12
Other primary headaches: Distinct clinical features and uncertain pathophysiology	12
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review	12
Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine	12
Mutation screening and association analysis of NOTCH3 p.R544C in patients with migraine with or without aura	12
Cephalalgia: a legacy of excellence, a vision for tomorrow	12
Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports	12
Response to letter to the Editor: Assessing migraine therapeutics	11
Comment on ‘'Correlation between endometriosis and migraine features: Results from a prospective case-control study'‘	11
A need for an expert consensus guideline on performing peripheral nerve blocks in headache patients	11
Persistent headache attributed to past cervicocephalic artery dissection: clinical characteristics and contributors to headache persistence	11
Epicranial headaches part 2: Nummular headache and epicrania fugax	11
Migraine and the risk of stroke in a middle-aged and elderly population: A prospective cohort study	11
How migraine and its associated treatment impact on pregnancy outcomes: Umbrella review with updated systematic review and meta-analysis	10
Lack of a direct link between macular cones function and photophobia in interictal migraine	10
Personal view: Modelling pain mechanisms of migraine without aura	10
The SIH-EBP Score: A grading scale to predict the response to the first epidural blood patch in spontaneous intracranial hypotension	10
Treatment experiences and clinical characteristics in migraine and tension-type headache patients before the first visit to a tertiary headache center	10
Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study	10
Developing an artificial intelligence-based headache diagnostic model and its utility for non-specialists’ diagnostic accuracy	10
Recovery and long-term outcome after neurosurgical closure of spinal CSF leaks in patients with spontaneous intracranial hypotension	10
Measuring headache day severity using multiple features in daily diary designs	10
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies	10
Overuse of analgesics can affect the fertility biomarker Anti-Müllerian Hormone in females. A translational study	10
Update in the understanding of new daily persistent headache	10
Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine	10
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study	10
Naratriptan is as effective as sumatriptan for the treatment of migraine attacks when used properly. A mini-review	10
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine	10
Multidisciplinary headache treatment with work-focus in Norway: An observational study	10
Headache provocation by nitric oxide in men who have never experienced a headache	10
Open label experience of repeated OnabotulinumtoxinA injections towards the sphenopalatine ganglion in patients with chronic cluster headache and chronic migraine	10
Pathophysiology of cluster headache: From the trigeminovascular system to the cerebral networks	10
Migraine and insufficient sleep: The effect of sleep restriction on nociceptive evoked potentials in migraine	9
Dysregulation of the peripheral glutamatergic system: A key player in migraine pathogenesis?	9
Migraine and risk of hypertensive disorders of pregnancy: A population-based cohort study	9
Investigations of the migraine-provoking effect of levcromakalim in patients with migraine with aura	9
Visual snow syndrome is probably not mediated by CGRP: A case series	9
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine	9
Phenotyping non-idiopathic pseudotumor cerebri syndrome – A prospective cohort study	9
Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial	9
Primary headache disorders in adolescents in North- and South-Tyrol: Findings of the EVA-Tyrol-Study	9
The evolutionary meaning of migraine	9

It is a long way to the top if you wanna citations?	9
Update on cough, exertional and sex headache	9
Effectiveness of physiotherapy interventions on headache intensity, frequency, duration and quality of life of patients with tension-type headache. A systematic review and network meta-analysis	9
A systematic evaluation of primary headache management apps leveraging behavior change techniques	9
The characteristics of COVID-19 vaccine-related headache: Clues gathered from the healthcare personnel in the pandemic	9
The influence of endogenous and exogenous hormonal factors on migraine in spontaneous postmenopausal women: A nationwide population-based study in South Korea	9
NCOR2 is a novel candidate gene for migraine-epilepsy phenotype	9
Investigations of the subarachnoid space as a potential link between aura and headache in migraine: A case-control MRI study	9
ANODYNE study: A double-blind randomized trial of greater occipital nerve block of methylprednisolone and lignocaine versus placebo as a transitional preventive treatment for episodic cluster headache	9
Transition of cluster headache phenotype: An interview-based study	9
Comment on: Setting higher standards for migraine prevention: A position statement of the International Headache Society	8
Corrigendum to: “CLOCK gene circannual expression in cluster headache”	8
Methodology of drug trials in migraine: History and suggestions for the future	8
Functional magnetic resonance imaging in migraine: A systematic review	8
What proportion of people with migraine report postdromal symptoms? A systematic review and meta-analysis of observational studies	8
Prolonged headache with vaccine- and dose-specific headache pattern associated with vaccine against SARS-CoV-2 in patients with migraine	8
Effect of KATP channel blocker glibenclamide on PACAP38-induced headache and hemodynamic	8
Identification of patients with chronic migraine by using sensory-evoked oscillations from the electroencephalogram classifier	8
Studying migraine as a risk factor for stroke: The importance of working with an explicit causal framework	8
Diagnosis of idiopathic intracranial hypertension: A proposal for evidence-based diagnostic criteria	8
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine	8
Preventive CGRP-targeted therapies for chronic migraine with and without medication-overuse headache	8
Aura in trigeminal autonomic cephalalgia is probably mediated by comorbid migraine with aura	8
A comparative study on prophylactic efficacy of cinnarizine and amitriptyline in childhood migraine: a randomized double-blind clinical trial	8
Characteristics of pre-cluster symptoms in cluster headache: A cross-sectional multicentre study	8
The monoclonal CGRP-receptor blocking antibody erenumab has different effects on brainstem and cortical sensory-evoked responses	8
Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two	8
Are PROMs passing the message? A reflection with real-life migraine patients	8
Identification of brain areas in mice with peak neural activity across the acute and persistent phases of post-traumatic headache	8
Thanks to Reviewers	8
Pharmacologic characterization of atogepant: A potent and selective calcitonin gene–related peptide receptor antagonist	8
Clinical analysis of 30 cases of cardiac cephalalgia	8
The prevalence of headache disorders in Postural Tachycardia Syndrome: A systematic review and meta-analysis of the literature	8
The chicken and egg problem: CGRP release due to trigeminal activation or vice versa?	8
Physical inactivity and headache disorders: Cross-sectional analysis in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)	7
Medication “underuse” headache	7
Prevalence, clinical characteristics and associated factors of cardiac cephalalgia: A prospective study	7
A response: Update on cough, exertional and sex headache	7
Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model	7
Genome-wide association study reveals susceptibility loci for self-reported headache in a large community-based Asian population	7
Indirect costs attributed to headache: A nation-wide survey of an active working population	7
No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study	7
Pharmacological modulation of ventral tegmental area neurons elicits changes in trigeminovascular sensory processing and is accompanied by glycemic changes: Implications for migraine	7
Enhanced audiovisual associative pair learning in migraine without aura in adult patients: An unexpected finding	7
Continuous positive airway pressure in cluster headache: A randomized, placebo-controlled, triple-blind, crossover study	7
Diagnosis, knowledge, perception, and productivity impact of headache education and clinical evaluation program in the workplace at an information technology company of more than 70,000 employees	7
20th Congress of the International Headache Society September 8-12, 2021	7
Author Index	7
Raising the bar in migraine prevention: Toward freedom and optimal control	7
Calcitonin receptor antibody validation and expression in the rodent brain	7
Migraine and the development of additional psychiatric and pain disorders in the transition from adolescence to adulthood	7
Epidemiology and clinical features of short-lasting unilateral neuralgiform headache attacks: A systematic review and meta-analysis	7
Functional brainstem representations of the human trigeminal cervical complex	7
Minimal important difference of the Migraine Disability Assessment (MIDAS): Longitudinal data from the DMKG Headache Registry	7
Building community and visibility: A year of social media growth for Cephalalgia	7
CLOCK gene circannual expression in cluster headache	7
Identification and characterization of migraine in pregnancy: A Norwegian registry-based cohort study	6
Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications	6
Pediatric screen exposure and school related headache disability	6
Response to letter to the editor: “What predicts citation counts and translational impact in headache research? A machine learning analysis”	6
The time sequence of brain MRI findings in spontaneous intracranial hypotension	6
Time to retire ‘New daily persistent headache’: Mode of onset of chronic migraine and tension-type headache	6
The epidemiology of airplane headache: A cross-sectional study on point prevalence and characteristics in 50,000 travelers	6
DNA-methylation and immunological response in medication overuse headache	6
Pain in the temple? Headache, muscle pain or both: A retrospective analysis	6
Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): Results of a randomized controlled trial	6
Interim analysis of the Registry for Load and Management of Medication Overuse Headache (RELEASE): A multicenter, comprehensive medication overuse headache registry	6
Effects of substance P on headache induction and arterial dilation in healthy adults	6
Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?	6
Longitudinal analysis of pain-induced brain activations in post-traumatic headache	6
PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation	6
Headache characteristics and postoperative course in Chiari I malformation	6
What do patients’ efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry	6
Long-term outcomes of nummular headache: A series of 168 patients and 1198 patient-years of follow-up	6
New migraine drugs	6
A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache	6
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis	6
Sex differences in effectiveness of CGRP receptor antagonism for treatment of acute and persistent headache-like pain in a mouse model of mild traumatic brain injury	6
The role of cytokines in migraine: A systematic review	6
Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data	6
Breaking barriers in migraine care: Advancing gender medicine to bridge the gap for men	5
Peripherally acting anti-CGRP monoclonal antibodies attenuate cortical resting-state connectivity in migraine patients	5
Effects of acupuncture and medical training therapy on depression, anxiety, and quality of life in patients with frequent tension-type headache: A randomized controlled study	5
Abstract Authors Index for MTIS 2022	5
Reply: The role of neurovascular contact in patients with multiple sclerosis	5
Reply to “What is the evolutionary disadvantage of migraine?”	5
Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study	5
Pain thresholds and suprathreshold pain after sleep restriction in migraine – A blinded crossover study	5
Thanks to Reviewers	5
Update on “Treatment of orthostatic headache without intracranial hypotension: A case report” – nine years later	5
Guidelines of the International Headache Society for Real-World Evidence studies in migraine and cluster headache	5
The headache and aura-inducing effects of sildenafil in patients with migraine with aura	5
Treatment pattern and response for cluster headache in Korea: A prospective multicenter observation study	5
Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation	5
The short-term effects of CGRP monoclonal antibodies on bone turnover: A prospective cohort study	5